Commentary: “Exploring the “Insight Paradox” in Treatment Resistant Schizophrenia: Correlations Between Dimensions of Insight and Depressive Symptoms in Patients Receiving Clozapine”

Detalles Bibliográficos
Autor principal: Stoyanov, Drozdstoy
Formato: Online Artículo Texto
Lenguaje:English
Publicado: AVES 2023
Materias:
Editorial Comment
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10334688/
https://www.ncbi.nlm.nih.gov/pubmed/37440896
http://dx.doi.org/10.5152/alphapsychiatry.2023.090523
_version_ 1785070912974880768
author Stoyanov, Drozdstoy
author_facet Stoyanov, Drozdstoy
author_sort Stoyanov, Drozdstoy
collection PubMed
description
format Online
Article
Text
id pubmed-10334688
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher AVES
record_format MEDLINE/PubMed
spelling pubmed-103346882023-07-12 Commentary: “Exploring the “Insight Paradox” in Treatment Resistant Schizophrenia: Correlations Between Dimensions of Insight and Depressive Symptoms in Patients Receiving Clozapine” Stoyanov, Drozdstoy Alpha Psychiatry Editorial Comment AVES 2023-05-01 /pmc/articles/PMC10334688/ /pubmed/37440896 http://dx.doi.org/10.5152/alphapsychiatry.2023.090523 Text en © 2023 authors https://creativecommons.org/licenses/by-nc/4.0/ Content of this journal is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License. (https://creativecommons.org/licenses/by-nc/4.0/)
spellingShingle Editorial Comment
Stoyanov, Drozdstoy
Commentary: “Exploring the “Insight Paradox” in Treatment Resistant Schizophrenia: Correlations Between Dimensions of Insight and Depressive Symptoms in Patients Receiving Clozapine”
title Commentary: “Exploring the “Insight Paradox” in Treatment Resistant Schizophrenia: Correlations Between Dimensions of Insight and Depressive Symptoms in Patients Receiving Clozapine”
title_full Commentary: “Exploring the “Insight Paradox” in Treatment Resistant Schizophrenia: Correlations Between Dimensions of Insight and Depressive Symptoms in Patients Receiving Clozapine”
title_fullStr Commentary: “Exploring the “Insight Paradox” in Treatment Resistant Schizophrenia: Correlations Between Dimensions of Insight and Depressive Symptoms in Patients Receiving Clozapine”
title_full_unstemmed Commentary: “Exploring the “Insight Paradox” in Treatment Resistant Schizophrenia: Correlations Between Dimensions of Insight and Depressive Symptoms in Patients Receiving Clozapine”
title_short Commentary: “Exploring the “Insight Paradox” in Treatment Resistant Schizophrenia: Correlations Between Dimensions of Insight and Depressive Symptoms in Patients Receiving Clozapine”
title_sort commentary: “exploring the “insight paradox” in treatment resistant schizophrenia: correlations between dimensions of insight and depressive symptoms in patients receiving clozapine”
topic Editorial Comment
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10334688/
https://www.ncbi.nlm.nih.gov/pubmed/37440896
http://dx.doi.org/10.5152/alphapsychiatry.2023.090523
work_keys_str_mv AT stoyanovdrozdstoy commentaryexploringtheinsightparadoxintreatmentresistantschizophreniacorrelationsbetweendimensionsofinsightanddepressivesymptomsinpatientsreceivingclozapine

Ejemplares similares